1.9 C
New York
Thursday, February 12, 2026

Sanofi Agrees to Pay $2.9 Billion For Provention Bio

Sanofi agreed to buy Provention Bio Inc. in a $2.9 billion deal intended to bolster the French drugmaker’s portfolio of diabetes medicines with a new …

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

149,538FansLike
396,312FollowersFollow
2,650SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x